Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodies

Overview of attention for article published in Molecular Therapy - Methods & Clinical Development, November 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter: 3 X users
patent: 3 patents

guideline: 1 clinical guideline source

Readers on

mendeley: 73 Mendeley

So far, Altmetric has seen 5 X posts from 3 X users, with an upper bound of 25,175 followers.

Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodies https://t.co/sN0tFNY837

2016 Nov 16. Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodies https://t.co/sN0tFNY837

RT @TAGHIVscience: Promise and problems associated with the use of recombinant AAV for the delivery of anti-#HIV antibodies https://t.co/vq…

Promise & Problems Associated w/ the Use of Recombinant AAV for the Delivery of Anti-#HIV Antibodies https://t.co/oQ5l41LBya

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.